(Total Views: 57)
Posted On: 10/25/2019 9:30:43 AM
Post# of 89362

$ALPMY News Article - European Commission Approves Astellas' XOSPATA(TM) (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation https://marketwirenews.com/news-releases/euro...33322.html


My Twitter: WhyteStocks